Stock G70 GALENICA AG
Add to a list
To use this feature you must be a member
Log inSign up

Company Galenica AG Deutsche Boerse AG

Equities

G70

CH0360674466

Pharmaceuticals

Delayed Deutsche Boerse AG
Other stock markets
 09:43:43 2019-06-28 am EDT 		5-day change 1st Jan Change
43.98 EUR -0.50% Intraday chart for Galenica AG -.--% -.--%
May. 23 Global markets live: Anglo American, Nvidia, Apple, Amazon, Tesla, Walt Disney... Our Logo
May. 23 Swiss Market Index Closes Little Changed; Julius Bär Gains MT

Business Summary

Galenica AG, previously Galenica Sante Ltd, is a Switzerland-based healthcare services and products provider. The Company's business i divided into three business sectors: Retail, Products & Brands, and Services. The Company manages a locally established pharmacies network in Switzerland. It develops and distributes its own product portfolio, as well as cooperates with a range of business partners, such as Pierre Fabre, Ales Groupe and Vitor Consumer Health for marketing and distribution of such brands as Perskindol, Triofan, A-Derma, Lierac, Phyto, Anti-Brumm and Algifor. Galenica Sante's Services business sector is responsible for management of such logistics sector companies as Galexis, Unione Farmaceutica Distribuzione, Alloga and Medifilm.

Number of employees: 6,181

Sales per Business

CHF in Million2022Weight2023Weight Delta
Logistics and Information Technology Services
59.1 %
2,080 51.8 % 2,213 59.1 % +6.42%
Products and Care
40.8 %
1,933 48.2 % 1,529 40.8 % -20.89%
Group Services
0.1 %
2 0.0 % 4 0.1 % +118.46%

Sales per region

CHF in Million2022Weight2023Weight Delta
Switzerland
98.9 %
3,979 99.1 % 3,706 98.9 % -6.88%
Other Countries
1.1 %
35 0.9 % 40 1.1 % +15.38%

Managers

Managers TitleAgeSince
Marc Werner CEO
 Chief Executive Officer 57 -
Felix Fritz Burkhard DFI
 Director of Finance/CFO 58 09-12-31
Lukas Ackermann CTO
 Chief Tech/Sci/R&D Officer 52 21-12-31
Virginie Pache PRN
 Corporate Officer/Principal 45 -
Jürg Pauli PRN
 Corporate Officer/Principal 60 19-12-31
Barbara Wälchli LAW
 General Counsel 43 19-12-31
Thomas Szuran SAM
 Sales & Marketing 57 18-12-31
Daniele Madonna PRN
 Corporate Officer/Principal - 17-04-06

Members of the board

Members of the board TitleAgeSince
Etienne Jornod CEO
 Chief Executive Officer 71 95-12-31
Jörg Zulauf BRD
 Director/Board Member 66 23-05-10
Andreas Stefan Walde BRD
 Director/Board Member 62 16-12-31
Markus Rudolf Neuhaus CHM
 Chairman 66 19-05-01
Pascale Bruderer BRD
 Director/Board Member 47 19-12-31
Bertrand Jungo BRD
 Director/Board Member 59 17-12-31
Judith Meier BRD
 Director/Board Member 62 22-05-10
Solange Peters BRD
 Director/Board Member - 23-05-10

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 50,000,000 49,718,651 ( 99.44 %) 167,820 ( 0.3356 %) 99.44 %

Shareholders

NameEquities%Valuation
UBS Asset Management Switzerland AG
5.342 %
2,671,158 5.342 % 205 M €
Credit Suisse Asset Management (Schweiz) AG
4.991 %
2,495,385 4.991 % 191 M €
Alecta Pension Insurance Mutual
4.000 %
2,000,000 4.000 % 153 M €
zCapital AG
1.021 %
510,550 1.021 % 39 M €
Union Bancaire Privée, UBP SA
0.5517 %
275,852 0.5517 % 21 M €
Banque Cantonale de Genève (Investment Management)
0.5326 %
266,290 0.5326 % 20 M €
Schweizerische Mobiliar Asset Management AG
0.4938 %
246,890 0.4938 % 19 M €
LLB Asset Management AG
0.4623 %
231,130 0.4623 % 18 M €
OLZ AG
0.3858 %
192,890 0.3858 % 15 M €
Alatus Capital SA
0.3715 %
185,764 0.3715 % 14 M €

Holdings

NameEquities%Valuation
REDCARE PHARMACY NV
7.88%
 1,602,120 7.88% 217,559,485 $
GALENICA AG
0.34%
 167,820 0.34% 12,854,337 $

Company contact information

Galenica AG

Untermattweg 8

3027, Bern

+41 58 852 81 11

http://www.galenica.com
address Galenica AG(G70)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Pharmaceuticals Wholesale

Sales per Business

Sales per region

Ratings for Galenica AG

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
74.7 CHF
Average target price
77 CHF
Spread / Average Target
+3.08%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Pharmaceuticals Wholesale

1st Jan change Capi.
MCKESSON CORPORATION Stock McKesson Corporation
+22.75% 74.04B
CARDINAL HEALTH, INC. Stock Cardinal Health, Inc.
-1.70% 24.18B
SINOPHARM GROUP CO. LTD. Stock Sinopharm Group Co. Ltd.
+3.42% 8.46B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD Stock Shanghai Pharmaceuticals Holding Co., Ltd
+8.55% 8.34B
HUADONG MEDICINE CO., LTD Stock Huadong Medicine Co., Ltd
-23.71% 7.64B
H. LUNDBECK A/S Stock H. Lundbeck A/S
+14.04% 5.33B
EBOS GROUP LIMITED Stock EBOS Group Limited
-6.90% 3.92B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD Stock Jointown Pharmaceutical Group Co., Ltd
+5.56% 3.89B
CHINA NATIONAL MEDICINES CORPORATION LTD. Stock China National Medicines Corporation Ltd.
+18.80% 3.54B
Pharmaceuticals Wholesale
  1. Stock Market
  2. Equities
  3. GALE Stock
  4. G70 Stock
  5. Company Galenica AG